IT9021091A0 - Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composi- zioni ottenute - Google Patents

Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composi- zioni ottenute

Info

Publication number
IT9021091A0
IT9021091A0 IT21091A IT2109190A IT9021091A0 IT 9021091 A0 IT9021091 A0 IT 9021091A0 IT 21091 A IT21091 A IT 21091A IT 2109190 A IT2109190 A IT 2109190A IT 9021091 A0 IT9021091 A0 IT 9021091A0
Authority
IT
Italy
Prior art keywords
procedure
preparation
active substance
compositions
dissolution speed
Prior art date
Application number
IT21091A
Other languages
English (en)
Other versions
IT9021091A1 (it
IT1246188B (it
Inventor
Ubaldo Conte
Manna Aldo La
Paolo Giunchedi
Original Assignee
Farma Resa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farma Resa filed Critical Farma Resa
Priority to IT02109190A priority Critical patent/IT1246188B/it
Publication of IT9021091A0 publication Critical patent/IT9021091A0/it
Priority to EP91112214A priority patent/EP0468392A1/en
Priority to CA002047944A priority patent/CA2047944C/en
Priority to JP21040791A priority patent/JP3488475B2/ja
Publication of IT9021091A1 publication Critical patent/IT9021091A1/it
Priority to US08/321,123 priority patent/US5476654A/en
Application granted granted Critical
Publication of IT1246188B publication Critical patent/IT1246188B/it
Priority to US08/524,739 priority patent/US5849329A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT02109190A 1990-07-27 1990-07-27 Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. IT1246188B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT02109190A IT1246188B (it) 1990-07-27 1990-07-27 Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
EP91112214A EP0468392A1 (en) 1990-07-27 1991-07-22 Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained
CA002047944A CA2047944C (en) 1990-07-27 1991-07-26 Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained
JP21040791A JP3488475B2 (ja) 1990-07-27 1991-07-29 活性物質の増大した溶解速度を有する薬剤組成物類の調製方法、および得られた組成物類
US08/321,123 US5476654A (en) 1990-07-27 1994-10-11 Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained
US08/524,739 US5849329A (en) 1990-07-27 1995-09-07 Process for preparing pharmaceutical composition having an increased active substance dissolution rate, and the compositions obtained

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02109190A IT1246188B (it) 1990-07-27 1990-07-27 Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.

Publications (3)

Publication Number Publication Date
IT9021091A0 true IT9021091A0 (it) 1990-07-27
IT9021091A1 IT9021091A1 (it) 1992-01-27
IT1246188B IT1246188B (it) 1994-11-16

Family

ID=11176602

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02109190A IT1246188B (it) 1990-07-27 1990-07-27 Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.

Country Status (5)

Country Link
US (2) US5476654A (it)
EP (1) EP0468392A1 (it)
JP (1) JP3488475B2 (it)
CA (1) CA2047944C (it)
IT (1) IT1246188B (it)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
WO1996026726A1 (en) * 1995-02-28 1996-09-06 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
IL123505A (en) 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CN1159012C (zh) * 1997-08-26 2004-07-28 阿旺蒂斯制药公司 用于组合哌啶子基烷醇-减充血剂的药物组合物
IT1294760B1 (it) 1997-09-03 1999-04-12 Jagotec Ag Procedimento per la preparazione di compresse farmaceutiche in grado di cedere,secondo schemi predeterminabili, principi attivi poco
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
AP1243A (en) * 1999-02-01 2004-02-02 Servier Lab Core tablet for controlled release of gliclazide after oral administration.
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
WO2001001955A1 (en) * 1999-07-02 2001-01-11 Janssen Pharmaceutica N.V. Nasal formulation of an antifungal
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
ES2304980T3 (es) * 1999-09-30 2008-11-01 Penwest Pharmaceuticals Co. Sistemas de matriz de liberacion sostenida para farmacos altamente solubles.
ATE268344T1 (de) * 2000-03-10 2004-06-15 Basf Ag Verwendung von quervernetztem polyvinylpyrrolidon als sprengmittel in kompakten, teilchenförmigen wasch- und reinigungsmitteln
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
ATE377413T1 (de) * 2001-06-29 2007-11-15 Eurand Pharmaceuticals Ltd Verfahren für die thermodynamische aktivierung von wasserlöslichen arzneimitteln, die in vernetzten polymeren geladen sind
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
WO2004054718A1 (en) * 2002-12-13 2004-07-01 Syngenta Participations Ag Process and device for coating a finely milled solid
JP4689468B2 (ja) * 2003-07-10 2011-05-25 協和発酵バイオ株式会社 錠剤およびその製造方法
WO2005105044A1 (en) * 2004-04-30 2005-11-10 Ranbaxy Laboratories Limited Process for making inclusion complex of sulfonylureas having improved aqueous solubility
ES2277743B2 (es) 2005-06-02 2008-12-16 Universidade De Santiago De Compostela Nanoparticulas que comprenden quitosano y ciclodextrina.
WO2007029093A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Pharmaceutical dosage forms of oxcarbazepine
US20070082870A1 (en) * 2005-10-11 2007-04-12 Buchanan Charles M Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
US8715731B2 (en) * 2006-03-22 2014-05-06 Isp Investments Inc. Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin
PE20150773A1 (es) * 2006-06-01 2015-05-21 Merck Sharp & Dohme Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
WO2008037044A1 (en) * 2006-09-27 2008-04-03 Medley S.A. Indústria Farmacêutica Oxcarbazepine-containing oral formulation and a process to obtain the same
EP2181705A1 (en) 2008-10-31 2010-05-05 Disphar International B.V. Sustained-release formulation of gliclazide
WO2016204939A1 (en) * 2015-06-19 2016-12-22 Biotie Therapies, Inc. Controlled-release tozadenant formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2948718A (en) * 1960-08-09 New n-heterocyclic compounds
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
JPS5132718A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Nanyoseiyakuhin no yoshutsusokudochosetsuho
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine

Also Published As

Publication number Publication date
IT9021091A1 (it) 1992-01-27
EP0468392A1 (en) 1992-01-29
JPH04234316A (ja) 1992-08-24
JP3488475B2 (ja) 2004-01-19
CA2047944C (en) 2002-03-12
US5849329A (en) 1998-12-15
US5476654A (en) 1995-12-19
CA2047944A1 (en) 1992-01-28
IT1246188B (it) 1994-11-16

Similar Documents

Publication Publication Date Title
IT9021091A0 (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composi- zioni ottenute
IT8822770A0 (it) Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
GB8729404D0 (en) Hydrosols of pharmacologically active agents & pharmaceutical compositions comprising them
PT87492A (pt) Process for the preparation of benzo ]b" pyrrans and pyranopyridines and pharmaceutical compositions containing them
IT1243541B (it) Dispositivo di somministrazione in particolare di sostanza farmaceutica
IT8821535A0 (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
ITMI913171A0 (it) Soluzione di farmaci con stabilita' aumentata a senza effetto dannoso sui tessuti e procedimento per la loro preparazione
FI904838A7 (fi) Menetelmä farmaseuttisesti aktiivisten karboksitetrahydroisokinoliinien ja niiden johdannaisten valmistamiseksi
IT1224574B (it) Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
FI915930A7 (fi) Uudet 15-nitro-2B, 3B-dihydro- ja nitro-2B, 3B, 6,7-tetrahydrotaversoniinijohdannaiset, farmaseuttiset koostumukset, jotka sisältävät niitä ja niiden valmistusmenetelmä
NO171728C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4'-demetylepipodofyllotoksin-glukosider
PT86933A (pt) Process for the preparation pf optically active oxo-isoindolinyul derivatives and of pharmaceutical compositions containing the same
IT8648217A0 (it) L-amminoacil derivati della l-carnitina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' epatoprotettrice che li contengono
IT8922446A0 (it) Procedimento per la preparazione di primicina idrosolubile e suoi componenti e composizioni farmaceutiche che li contengono
IT8922129A0 (it) Impiego dell'isosorbide 2-mononitrato per la preparazione di composizioni farmaceutiche atte al trattamento dell'angina pectoris
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant
IT1243994B (it) Dispositivo per la preparazione estemporanea e l'erogazione di soluzioni
IT1204839B (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione
IT8620737A1 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730